BRIDGEBIO PHARMA INC.
27.49
27-November-24 15:45:00
15 minutes delayed
Stocks
+1.05
+3.97%
Today's range
26.25 - 28.20
ISIN
N/A
Source
NASDAQ
-
12 May 2022 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in the Bank of America Securities Healthcare Conference
10 May 2022 15:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports First Quarter 2022 Financial Results and Business Update
05 May 2022 06:30:02 By Nasdaq GlobeNewswire
-
03 Apr 2022 07:36:00 By Nasdaq GlobeNewswire
-
11 Mar 2022 06:30:00 By Nasdaq GlobeNewswire
-
08 Mar 2022 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Business Update
24 Feb 2022 06:30:00 By Nasdaq GlobeNewswire
-
27 Jan 2022 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Month 12 Topline Results from Phase 3 ATTRibute-CM Study
27 Dec 2021 06:00:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10 Dec 2021 06:30:00 By Nasdaq GlobeNewswire
-
19 Nov 2021 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma, Inc. Secures Up to $750 Million in Non-Dilutive Debt Financing
18 Nov 2021 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
14 Jun 2021 15:35:00 By Nasdaq GlobeNewswire
-
01 Jun 2021 06:30:00 By Nasdaq GlobeNewswire
-
28 May 2021 13:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
14 May 2021 15:30:00 By Nasdaq GlobeNewswire
-
14 May 2021 06:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma, Inc. Reports First Quarter 2021 Financial Results And Business Update
06 May 2021 06:30:01 By Nasdaq GlobeNewswire